"A lot of people cannot afford life-saving drugs. Drug re-importation provides an alternative supply at lower prices for people who cannot afford the full price," said Dr. Peter Rost, Pfizer [3]'s vice president of marketing for endocrine care and the first drug industry [4] executive to publicly support reimporting drugs from Canada to America. Although Rost's support of reimportation was done on his own time, Pfizer recently launched an investigation into his political activities. "The questioning was intense," Rost remarked [5] - and biased, he claims. "If I had spoken out against reimportation they would have sent me flowers."